Eliem Therapeutics, Inc.

NASDAQ:ELYM

5.11 (USD) • At close October 2, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -8.666-20.781-13.67-8.895-54.889-1.697-3.641-3.968-5.22-22.29-7.762-9.682-14.596-13.204-10.545-9.615-8.719-18.601-14.863-2.258-1.631-1.916
Depreciation & Amortization 0.707-0.669-1.185-0.1690-0.0630.49100-0.491-0.29300.2930.1930.370000000
Deferred Income Tax 0000000000-1.3900-0.193-1.8450000000
Stock Based Compensation 1.0132.0223.3782.9220.5120.4651.2020.6560.77710.1711.8951.7831.7721.5411.1541.2361.050.2970.4730.0490.0510.134
Change In Working Capital 00-2.761-1.3141.98-0.641.4217.473-2.672-2.458-0.4842.69-2.4020.4061.22-4.592-0.727-0.0730.026-0.341-2.161-0.46
Accounts Receivables 0000000000000000000000
Change In Inventory 0000000000000000000000
Change In Accounts Payables 0.0930.0720.864-0.222-1.1750.02-0.672-0.1420.0140.114-0.7440.4310.146-0.486-1.1680.527-0.1290.92-0.0470.466-0.4890.046
Other Working Capital 00-3.433-1.0921.98-0.642.0937.615-2.686-0.1140.262.277-2.5480.8922.388-5.119-0.598-0.9930.073-0.807-1.672-0.506
Other Non Cash Items -4.2023.9942.109-0.09952.2420.5180.071-0.671-0.85-0.109-0.4150.1120.9670.4781.7620.004-0.08511.6378.740.169-0.027-0.083
Operating Cash Flow -11.148-15.434-12.129-7.555-0.667-1.819-0.9473.49-7.965-15.177-8.449-4.175-13.966-10.779-7.884-12.967-8.481-6.74-5.624-2.381-3.768-2.325
Investing Activities:
Investments In Property Plant And Equipment -0.077000000000000000000000
Acquisitions Net 0000-4.64500000000000008.279000
Purchases Of Investments -20.619-58.751-132.196-71.78900-0.001-2.463-38.533-17.452-6.714-46.742-8.926-25.581-8.051-106.919000000
Sales Maturities Of Investments 25.48216-29.750013.75136.74930.536.93223.24920.99255.25124.61421.54600000000
Other Investing Activites 0000-513.7510.0370.028-0.0020.0060.0148.5090.016-4.035-8.051-106.919008.078000
Investing Cash Flow 4.786-42.751-161.946-71.789-9.64513.75136.74828.037-1.6015.79714.2788.50915.688-4.035-8.051-106.919008.078000
Financing Activities:
Debt Repayment 0000000000000000000000
Common Stock Issued 00-8.9550128.4020.0150.2880.5280.0240.00100000.03883.14459.96734.0830000
Common Stock Repurchased 0000000000000000000000
Dividends Paid 000000000000-2.1410-4.5480-2.14100000
Other Financing Activities 002.0242.271128.4020.0150.2880.5280.0240.001002.14100.03883.14462.10834.0834.925000
Financing Cash Flow 002.0242.271128.4020.0150.2880.5280.0240.00100-2.14100.03883.14459.96734.0834.925000
Other Information:
Effect Of Forex Changes On Cash 0.024-0.0240.3810.1080.019-0.028-0.330.0040.3990.2311.812-0.992-1.051-0.177104.5380.0790.0850.0810.418-0.1690.0270.083
Net Change In Cash -6.338-58.209-135.911-76.965118.10911.91935.75932.059-9.143-9.1487.6413.3420.671-14.991-15.897-36.66351.57127.4247.797-2.55-3.741-2.242
Cash At End Of Period 22.68229.0287.229146.175223.14105.03193.11257.35325.29434.43743.58535.94432.60231.93146.92262.81999.48247.91120.48712.6915.2418.981